Showing 5,860 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

PrEP policies & guidelines

Simpler PrEP services – fewer check-ups, online care – work as well as the standard approach

News
20 March 2025
Injectable & long-acting HIV treatment

Uganda's experiences implementing long-acting injectable ART to combat HIV/AIDS

Editor's pick
Be In The Know
19 March 2025
Injectable & long-acting HIV treatment

Long-Acting Injectables Work Well for People Without Viral Suppression

Editor's pick
POZ
19 March 2025
New & experimental HIV treatments

ACTG Presents Study at CROI Demonstrating Potential of CMV-specific Antiviral Inhibitor to Improve Aging-Related Outcomes among People Living with HIV and CMV

Editor's pick
GlobeNewswire
18 March 2025
PrEP science

HIV acquisition in women with good adherence to TAF/FTC PrEP is rare

News
17 March 2025
Injectable & long-acting HIV treatment

New long-acting HIV drugs show promising early results

News
17 March 2025
Antibody-based treatment

Broadly neutralising antibody N6LS could be part of long-acting HIV treatment

News
17 March 2025
Treatment simplification strategies

Reducing Biktarvy from daily to only once, twice or three times a week

Editor's pick
i-Base
17 March 2025
Adherence

Urine testing plus feedback can increase PrEP adherence in pregnant women

Editor's pick
Healio
17 March 2025
Low CD4 count

Treatment Options for People With Advanced HIV Disease at Diagnosis: Interview With Georg Behrens, M.D., Ph.D.

Editor's pick
TheBodyPro
17 March 2025
Chemsex & recreational drug use

FDA reportedly raids manufacturer of poppers, an increasingly popular party drug

Editor's pick
NBC News
17 March 2025
New & experimental HIV treatments

Studies confirm non-inferiority of doravirine / islatravir to standard HIV treatment

News
17 March 2025
Retention & linkage to care

PEPFAR study shows the deadly impact of stopping children’s HIV treatment

News
12 March 2025
Injectable & long-acting HIV treatment

Lenacapavir plus broadly neutralising antibodies could be twice-yearly HIV treatment

News
12 March 2025
Antibody-based treatment

Half the men in an HIV cure study stayed off treatment for nearly a year after a two-antibody shot

News
12 March 2025
Access to healthcare

2024 HIV Mid-Year Market Memo

Editor's pick
Clinton Health Access Initiative
17 July 2024
HIV treatment

New Unitaid report: World's leading HIV drug proven to have reduced global CO2 emissions by 26 million tons

Editor's pick
Unitaid
15 July 2024
Cancer

US: HIV Clinical Guidelines Now Recommend High Resolution Anoscopy as Part of Anal Cancer Screening Program for People with HIV

Editor's pick
National Institutes of Health
10 July 2024
Injectable & long-acting HIV treatment

Long-Acting Injectables Are Effective for Homeless People

Editor's pick
POZ
10 July 2024
Changing treatment

Dolutegravir resistance very rare after a switch - even with detectable HIV

News
8 July 2024
Kidney problems

Patients with HIV who get therapy may have similar CKD results vs. patients who defer care

Editor's pick
Healio
5 July 2024
Adherence

Most people on dolutegravir resuppress viral load after a detectable result

News
5 July 2024
Resistance

Lamivudine resistance mutation may persist for many years in some people with HIV

News
4 July 2024
Retention & linkage to care

Retention in HIV care has declined since 'Treat All' guidelines introduced

News
28 June 2024